ADAM10 is the physiologically relevant, constitutive α‐secretase of the amyloid precursor protein in primary neurons

Kuhn, Peer‐Hendrik, Wang, Huanhuan, Dislich, Bastian, Colombo, Alessio, Zeitschel, Ulrike, Ellwart, Joachim W, Kremmer, Elisabeth, Roßner, Steffen +1 more·2010·The EMBO Journal

Cited by (624)

Items 401–500 of 624

  1. Munc13 genotype regulates secretory amyloid precursor protein processing via postsynaptic glutamate receptors
    Maike Hartlage‐Rübsamen, Alexander Waniek, Steffen Roßner · 2012 · International Journal of Developmental Neuroscience
  2. Regulation of Alzheimer's disease-associated proteins during epileptogenesis
    Eva‐Lotta von Rüden, Christina Zellinger, Julia Gedon, Andreas Walker, Vera Bierling, Cornelia A. Deeg, Stefanie M. Hauck, Heidrun Potschka · 2019 · Neuroscience
  3. The effect of age and obesity on platelet amyloid precursor protein processing and plasma markers of oxidative stress and inflammation
    Richard J. Elsworthy, Sarah Aldred · 2020 · Experimental Gerontology
  4. Regulation of ADAM10 by MicroRNA-23a Contributes to Epileptogenesis in Pilocarpine-Induced Status Epilepticus Mice
    Xinjian Zhu, Yuanyuan Yao, Yaoyao Liu, Rong Zhou, Wei Zhang, Qiang Hu, Hang Liu, Mohammed Hidayath Al Hamda, Aifeng Zhang · 2019 · Frontiers in Cellular Neuroscience
  5. The transmembrane domain of the amyloid precursor protein is required for antiamyloidogenic processing by α-secretase ADAM10
    Hitschler, Lisa, Lang, Thorsten · 2022 · Journal of Biological Chemistry
  6. Effect of Lycoris chejuensis and Its Active Components on Experimental Models of Alzheimer’s Disease
    Joonki Kim, Yurim Park, Yoon Sun Chun, Jin Wook Cha, Hak Cheol Kwon, Myung Sook Oh, Sungkwon Chung, Hyun Ok Yang · 2015 · Journal of Agricultural and Food Chemistry
  7. Effects of conjugated linoleic acid on cleavage of amyloid precursor protein via PPARγ
    Yi‐Chen Li, Qing Chen, Xianzi Wan, Xiangling Yang, Xin Liu, Ling Zhong · 2011 · Neurological Sciences
  8. Genetic Association Between APP, ADAM10 Gene Polymorphism, and Sporadic Alzheimer’s Disease in the Chinese Population
    Fan Zeng, Cheng Shen, Yu-Hui Liu, Jing Li, Jie Zhu, Ye‐Ran Wang, Yan Jia-chuan, Chang-Yue Gao, Huadong Zhou, Juan Deng et al. · 2015 · Neurotoxicity Research
  9. Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function
    María Borrell-Pagés, Aureli Luquero, Gemma Vilahur, Teresa Padró, Lina Badimón · 2023 · Cardiovascular Research
  10. Alzheimer’s Disease: A Review of Molecular Mechanisms and Therapeutic Implications by Targeting Sirtuins, Caspases, and GSK-3
    Kalpana Pandya, Krishnashish Roul, Avanish Tripathi, Sateesh Belemkar, Anshuman Sinha, Meryem Erol, Devendra Kumar · 2025 · ACS Chemical Neuroscience
  11. Novel disease-modifying therapeutics for the treatment of Alzheimer’s disease
    Gabriel C. Léger, Fadi Massoud · 2013 · Expert Review of Clinical Pharmacology
  12. The amyloid-β peptide: Guilty as charged?
    Michael Paul Murphy, Valeria A. Buzinova, Carrie E. Johnson · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  13. APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
    Simon Sjödin, Kerstin K. A. Andersson, Marc H. Mercken, Henrik Zetterberg, Herman Borghys, Kaj Blennow, Erik Portelius · 2015 · Alzheimer s Research & Therapy
  14. Anodal transcranial direct current stimulation alleviates cognitive impairment in an APP/PS1 model of Alzheimer’s disease in the preclinical stage
    Yin-Pei Luo, Zhi Liu, Cong Wang, Xiu-Fang Yang, Xiao-Ying Wu, Xue-Long Tian, Huizhong Wen · 2022 · Neural Regeneration Research
  15. Novel aspects of the apolipoprotein-E receptor family: regulation and functional role of their proteolytic processing
    Larios, Jorge A., Marzolo, Maria-Paz · 2012 · Frontiers in Biology
  16. N-truncated Aβ peptides in complex fluids unraveled by new specific immunoassays
    Sébastien Ranaldi, Céline Caillava, Sylvie Promé, Laëtitia Rubrecht, Sandra Cobo, Nicolas Salvetat, Emilie Du Paty, Pascale Galéa, Gudrun Aldrian, Dung Le‐Nguyen et al. · 2012 · Neurobiology of Aging
  17. A New Mint1 Isoform, but Not the Conventional Mint1, Interacts with the Small GTPase Rab6
    Anika Thyrock, Edith Ossendorf, Martin Stehling, Mark Kail, Tanja Kurtz, Gottfried Pohlentz, Dieter Waschbüsch, Simone Eggert, Étienne Formstecher, Johannes Müthing et al. · 2013 · PLoS ONE
  18. Antioxidative effects of ethyl 2-(3-(benzo[d]thiazol-2-yl)ureido)acetate against amyloid β-induced oxidative cell death via NF-κB, GSK-3β and β-catenin signaling pathways in cultured cortical neurons
    E.-A. Kim, C. H. Cho, D. W. Kim, Soo Young Choi, Jin Won Huh, S.-W. Cho · 2015 · Free Radical Research
  19. A New Sandwich Immunoassay for Detection of the α-Secretase Cleaved, Soluble Amyloid-β Protein Precursor in Cerebrospinal Fluid and Serum
    Mara Taverna, Tobias Straub, Harald Juergen Hampel, Dan Rujescu, Stefan F. Lichtenthaler · 2013 · Journal of Alzheimer s Disease
  20. Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases
    Feizhi Song, Valerija Kovač, Behnam Mohammadi, Jessica Lisa Littau, Franka Scharfenberg, Andreu Matamoros‐Angles, Ilaria Vanni, Mohsin Shafiq, Leonor Orge, Giovanna Galliciotti et al. · 2024 · Acta Neuropathologica
  21. Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets.
    Payal Chauhan, Karan Wadhwa, Govind Singh · 2025 · Pathology, Research and Practice
  22. Single-nucleus multi-omics identifies shared and distinct pathways in Pick’s and Alzheimer’s disease
    Zechuan Shi, Sudeshna Das, Samuel Morabito, Jennifer T. Stocksdale, Emily Miyoshi, Shushrruth Sai Srinivasan, Nora Emerson, Arshi Shahin, Negin Rahimzadeh, Zhenkun Cao et al. · 2025 · Science Advances
  23. Enhanced cleavage of APP by co-expressed Bace1 alters the distribution of APP and its fragments in neuronal and non-neuronal cells
    Jonathan Aow, Tzu-Rung Huang, Gopal Thinakaran · 2022 · Molecular Neurobiology
  24. Tetraspanin-29 activates Notch signaling by interacting with ADAM10 to enhance its activity in colorectal cancer
    Shijie Yuan, Yan Yin, Kuansong Wang · 2022 · Biochemistry and Cell Biology
  25. Micro-RNA profiles of pathology and resilience in posterior cingulate cortex of cognitively intact elders
    Christy M. Kelley, Bryan Maloney, John S. Beck, Stephen D. Ginsberg, Winnie S. Liang, Debomoy K. Lahiri, Elliott Jay Mufson, Scott Counts · 2024 · Brain Communications
  26. A possible role of glycation in the regulation of amyloid β precursor protein processing leading to amyloid β accumulation
    Gouri V. Patil, Rakesh S. Joshi, Rubina S. Kazi, Shabda E Kulsange, Mahesh J. Kulkarni · 2020 · Medical Hypotheses
  27. Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development
    Emily X. Dexter, Qingzhong Kong · 2021 · Expert Review of Neurotherapeutics
  28. Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts
    Andreu Matamoros‐Angles, Behnam Mohammadi, Feizhi Song, Mohsin Shafiq, Santra Brenna, Berta Puig, Markus Glatzel, Hermann C. Altmeppen · 2023 · Neural Regeneration Research
  29. α‐Secretase cleaved amyloid precursor protein ( APP ) accumulates in cholinergic dystrophic neurites in normal, aged hippocampus
    S.‐Y. Yoon, J.‐U. Choi, Min Cho, Keyi Yang, H. Ha, Ik Jo Chung, G. S. Cho, Do Hoon Kim · 2013 · Neuropathology and Applied Neurobiology
  30. shRNA-mediated silencing of TARBP2 inhibits NCI-H1299 non-small cell lung cancer cell invasion and migration via the JNK/STAT3/AKT pathway
    Yue Xi Shi, Duo Zuo, Xia Wang · 2016 · Molecular Medicine Reports
  31. The Genetic Basis of Alzheimer's Disease
    Basavaraj V. Hooli, Rudolph E. Tanzi · 2016 · Elsevier eBooks
  32. A combinational treatment of carotenoids decreases Aβ secretion in human neurons via β-secretase inhibition
    Misato Sho, Naoki Ichiyanagi, Kent Imaizumi, Mitsuru Ishikawa, Satoru Morimoto, Hirotaka Watanabe, Hideyuki Okano · 2019 · Neuroscience Research
  33. Natural Modulators of Amyloid-Beta Precursor Protein Processing.
    C Zhang, Rudolph E. Tanzi · 2012 · PubMed
  34. Alzheimer’s Disease and Dementia
    Patrick Alfryn Lewis, Jennifer E. Spillane · 2018 · Elsevier eBooks
  35. Interactions between daily sleep-wake rhythms, γ-secretase, and amyloid-β peptide pathology point to complex underlying relationships
    Savannah M. Turton, Samantha Padgett, Michael Tyler Jessup, Carrie E. Johnson, Valeria A. Buzinova, Sarah E. Barth, Katharina Köhler, Heather M. Spearman, Teresa Macheda, Elena C. Manauis et al. · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  36. Discovery of an APP-selective BACE1 inhibitor for Alzheimer's disease
    Jesus J. Campagna, B. Jagodzinska, Dongwook Wi, Chun-Ni Zhu, Jessica T. Lee, W. Cohn, Michael Jun, C. Elias, Samar Padder, O. Descamps et al. · 2023 · bioRxiv
  37. Circulating micro-RNAs Differentially Expressed in Korean Alzheimer’s Patients With Brain Aβ Accumulation Activate Amyloidogenesis
    Sakulrat Mankhong, Sujin Kim, Sohee Moon, Seong-Hye Choi, Hyo‐Bum Kwak, Dong‐Ho Park, Pratik Shah, Phil Hyu Lee, Seong Wook Yang, Ju‐Hee Kang · 2022 · The Journals of Gerontology Series A
  38. Membrane trafficking and proteolytic activity of γ-secretase in Alzheimer’s disease
    Kunihiko Kanatsu, Taisuke Tomita · 2016 · Biological Chemistry
  39. Curcumin effect on non-amyloidogenic pathway for preventing Alzheimer’s disease
    2019 · Biointerface Research in Applied Chemistry
  40. Looking at Alzheimer’s Disease Pathogenesis from the Nuclear Side
    Laura D’Andrea, Ramona Stringhi, Mónica Di Luca, Elena E. Marcello · 2021 · Biomolecules
  41. Clinicopathological Significance of TARBP2, APP, and ZNF395 in Breast Cancer
    Ryoko Oi, Hirotaka Koizumi, Ichiro Maeda, Akira Noguchi, Shinobu Tatsunami, Tsuguo Iwatani, Hisanori Kawamoto, Koichiro Tsugawa, Masayuki Takagi · 2016 · Breast Cancer Basic and Clinical Research
  42. Nuclear localization of amyloid-β precursor protein-binding protein Fe65 is dependent on regulated intramembrane proteolysis
    Niina A. Koistinen, Anna K. Edlund, Preeti Kumaran Menon, Elena V. Ivanova, Smaranda Bacanu, Kerstin Iverfeldt · 2017 · PLoS ONE
  43. Substrate-Specific Activation of α-Secretase by 7-Deoxy-Trans-Dihydronarciclasine Increases Non-Amyloidogenic Processing of β-Amyloid Protein Precursor
    Yoon Sun Chun, Yoon Young Cho, Oh-Hoon Kwon, Dong Feng Zhao, Hyun Ok Yang, Sungkwon Chung · 2020 · Molecules
  44. The cellular expression and proteolytic processing of the amyloid precursor protein is independent of TDP-43
    David A. Hicks, Alys C. Jones, Stuart M. Pickering-Brown, Nigel M. Hooper · 2020 · Bioscience Reports
  45. Phosphorylation of meprin β controls its cell surface abundance and subsequently diminishes ectodomain shedding
    Fred Armbrust, Kira Bickenbach, Tomáš Koudelka · 2021 · The FASEB Journal
  46. Preventing Expression of the Nicotinic Receptor Subunit α7 in SH-SY5Y Cells with Interference RNA Indicates that this Receptor may Protect Against the Neurotoxicity of Aβ
    Xiao-lan Qi, Kai Ou-Yang, Jia-mou Ren, Chang-Xue Wu, Yan Xiao, Yi Li, Z. Guan · 2013 · Neurochemical Research
  47. Role of Metalloproteinases in Diabetes-associated Mild Cognitive Impairment
    Vitória Mattos Pereira, Suyasha Pradhanang, Jonathan F. Prather, Sreejayan Nair · 2024 · Current Neuropharmacology
  48. Structural insights into the activation and inhibition of the ADAM17–iRhom2 complex
    Joseph J. Maciag, Conner E. Slone, Hala F. Alnajjar, Maria F. Rich, Bryce Guion, Igal Ifergan, Carl Blobel, Tom C. M. Seegar · 2025 · Proceedings of the National Academy of Sciences
  49. The Rab5 activator RME-6 is required for amyloid precursor protein endocytosis depending on the YTSI motif
    Simone Eggert, Tomas Gruebl, Ritu Rajender, Carsten Rupp, Bianca Sander, Amelie Heesch, Marius Zimmermann, Sebastian Hoepfner, Hanswalter Zentgraf, Stefan Kins · 2020 · Cellular and Molecular Life Sciences
  50. Phosphodiesterase 4D Gene Modifies the Functional Network of Patients With Mild Cognitive Impairment and Alzheimer’s Disease
    Jie Xiang, Xin Wang, Yuan Gao, Ting Li, Rui Cao, Ting Yan, Yunxiao Ma, Yan Niu, Jiayue Xue, Bin Wang · 2020 · Frontiers in Genetics
  51. Endoglycan (PODXL2) is proteolytically processed by ADAM10 (a disintegrin and metalloprotease 10) and controls neurite branching in primary neurons
    Hung‐En Hsia, Johanna Tüshaus, Xiao Ming Feng, Laura I. Hofmann, Benedikt Wefers, Denise K. Marciano, Wolfgang Wurst, Stefan F. Lichtenthaler · 2021 · The FASEB Journal
  52. Lemur tail kinase 1 (LMTK1) regulates the endosomal localization of β-secretase BACE1
    Keisuke Komaki, Tetsuya Takano, Yutaka Satō, Akiko Asada, Shikito Ikeda, Kaoru Yamada, Ran Wei, Anni Huo, Aoi Fukuchi, Taro Saito et al. · 2021 · The Journal of Biochemistry
  53. Therapeutic Potential of Targeting Regulated Intramembrane Proteolysis Mechanisms of Voltage-Gated Ion Channel Subunits and Cell Adhesion Molecules
    Samantha L. Hodges, Alexandra A. Bouza, Lori L. Isom · 2022 · Pharmacological Reviews
  54. Biomarkers in Alzheimer’s Disease: Are Olfactory Neuronal Precursors Useful for Antemortem Biomarker Research?
    Valeria Santillán-Morales, Norberto Rodriguez-Espinosa, Jesús Muñoz-Estrada, Salvador Alarcón-Elizalde, Á. Acebes, G. Benítez-King · 2024 · Brain Science
  55. The Protective Role of Coffea arabica L. and Crocus sativus L. Against the Neurotoxicity Induced by Chronic Administration of Aluminium Chloride
    Fahmy G. Elsaid, Ali Abdullah Shati, E. S. E. Hafez · 2011 · Journal of Pharmacology and Toxicology
  56. Exercise for the prevention of Alzheimer's disease: Multiple pathways to promote non-amyloidogenic AβPP processing
    Richard J. Elsworthy, Connor Dunleavy, Martin Whitham, Sarah Aldred · 2022 · Aging and Health Research
  57. The structure of an amyloid precursor protein/talin complex indicates a mechanical basis of Alzheimer’s disease
    2024
  58. ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels
    Pablo Agüero, Julián Pérez‐Pérez, Lucía Cremades‐Jimeno, María‐Salud García‐Ayllón, Adriana Gea‐González, María José Sainz, Ignacio Mahíllo, Raquel Téllez, Blanca Cárdaba, Javier Sáez‐Valero et al. · 2023 · International Journal of Molecular Sciences
  59. NRF2 activation by 6-MSITC increases the generation of neuroprotective, soluble α amyloid precursor protein by inducing the metalloprotease gene ADAM17
    Daniel Carnicero-Senabre, José Jiménez-Villegas, Sofía Álvarez-Garrote, Maribel Escoll, Antonio Cuadrado, Ana Isabel Rojo · 2024 · Free Radical Biology and Medicine
  60. Regulation of podocyte surface proteins by the enzyme A Disintegrin And Metalloproteinase 10 (ADAM10)
    David Rosenbaum, Julia Reichelt, Simonas Gudaitis et al. · 2025 · Kidney International
  61. Autophagy-Dependent Increased ADAM10 Mature Protein Induced by TFEB Overexpression Is Mediated Through PPARα
    Hongjie Wang, Mohan Kumar Muthu Karuppan, Madhavan Nair, Madepalli Krishnappa Lakshmana · 2021 · Molecular Neurobiology
  62. A Bioengineering Strategy to Control ADAM10 Activity in Living Cells
    Francesco Pastore, Martina Battistoni, Raimondo Sollazzo, Pietro Renna, Fabiola Paciello, Domenica Donatella Li Puma, Eugenio Barone, Onur Dağliyan, Cristian Ripoli, Claudio Grassi · 2023 · International Journal of Molecular Sciences
  63. Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals
    Giulia Cencelli, Laura Pacini, Anastasia De Luca, Ilenia Messia, Antonietta Gentile, Yunhee Kang, Veronica Nobile, Elisabetta Tabolacci, Peng Jin, Maria Giulia Farace et al. · 2023 · Cells
  64. Escape from X-chromosome inactivation and sex differences in Alzheimer’s disease
    Qing-Hua Song, Ke-Xuan Zhao, Shuai Huang, Tong Chen, Ling He · 2023 · Reviews in the Neurosciences
  65. Dropping the BACE: Beta Secretase (BACE1) as an Alzheimer’s Disease Intervention Target
    Justin L. Read, Cenk Suphioglu · 2013 · InTech eBooks
  66. Mapping orphan proteases by proteomics: Meprin metalloproteases deciphered as potential therapeutic targets
    Christoph Becker‐Pauly, Claudia Broder, Johannes Prox, Tomáš Koudelka, Andreas Tholey · 2014 · PROTEOMICS - CLINICAL APPLICATIONS
  67. Fluorescent Analogue of Batimastat Enables Imaging of α-Secretase in Living Cells
    Geoffray Leriche, Allen C. Chen, Sumin Kim, Dennis J. Selkoe, Jerry Yang · 2015 · ACS Chemical Neuroscience
  68. The Genetic Basis of Alzheimer’s Disease
    Basavaraj V. Hooli, Rudolph E. Tanzi · 2016 · Elsevier eBooks
  69. Phenanthroline impairs βAPP processing and expression, increases p53 protein levels and induces cell cycle arrest in human neuroblastoma cells
    Subhamita Maitra, Wannapa Sornjai, Duncan Richard Smith, Bruno Vincent · 2021 · Brain Research Bulletin
  70. A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease
    Arun Mittal, Rupali Sharma, Satish Sardana, Parveen Kumar Goyal, Mona Piplani, Anima Pandey · 2022 · CNS & Neurological Disorders - Drug Targets
  71. The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
    Tenielle Porter, Aleksandra Gozt, Francis L. Mastaglia, Simon Matthew Laws · 2019 · Wiley eBooks
  72. Voluntary wheel running decreases amyloidogenic pathway and rescues cognition and mitochondrial energy metabolism in middle-aged female 3xTg-AD mouse model of Alzheimer's disease
    Jonathas Rodrigo dos Santos, Carlos Henrique Rocha Catalão, Anderson Vulczak, Ana Elisa Caleiro Seixas Azzolini, Luciane C. Alberici · 2024 · Journal of Alzheimer s Disease
  73. Substrate Selection Criteria in Regulated Intramembrane Proteolysis
    Céline Moser, Nadja Guschtschin-Schmidt, Mara Silber, Julia Flum, Claudia Muhle‐Goll · 2024 · ACS Chemical Neuroscience
  74. Therapeutic effects of a novel synthetic α-secretase
    Sung Bin Kim, Bo-Ram Mun, Sung Yoon Kim, Muthukumar Elangovan, Euy Jun Park, Won‐Seok Choi, Woo Jin Park · 2024 · Frontiers in Aging Neuroscience
  75. The late-onset Alzheimer’s disease risk factor RHBDF2 is a modifier of microglial TREM2 proteolysis
    Georg Jocher, Stephan A. Müller, Hung‐En Hsia, Miranda Lastra Osua, Gözde Özcelik, Laura I. Hofmann, Marlene Aßfalg, Lina Dinkel, Xiao Ming Feng, Kai Schlepckow et al. · 2025 · Life Science Alliance
  76. Implications of Mucin-Type O-Glycosylation in Alzheimer’s Disease
    Nancy Vela Navarro, Gustavo De Nadai Mundim, Mare Čudić · 2025 · Molecules
  77. γ-Secretase regulates the α-secretase cleavage of the Alzheimer’s disease, amyloid precursor protein
    Barbara M. Siegenthaler, Jitin Bali, Lawrence Rajendran · 2016 · Matters
  78. Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact
    Thomas Gabriel Schreiner, Bogdan Ovidiu Popescu · 2021 · Journal of Clinical Medicine
  79. The Role of Non-coding RNAs in Alzheimer’s Disease: Pathogenesis, Novel Biomarkers, and Potential Therapeutic Targets
    Othman Mohammad Saleh, Khaled Anwer Albakri, Abdalrahmn Altiti, Iser Abutair, Suhaib S. Shalan, Omar Bassam Mohd, Ahmed Negida, Gohar Mushtaq, Mohammad Amjad Kamal · 2023 · CNS & Neurological Disorders - Drug Targets
  80. Alpha-secretase dependent nuclear localization of the amyloid-β precursor protein-binding protein Fe65 promotes DNA repair
    Rebecca Revol, Niina A. Koistinen, Preeti Kumaran Menon, Almudena Chicote‐González, Kerstin Iverfeldt, Anna‐Lena Ström · 2023 · Molecular and Cellular Neuroscience
  81. Auraptene Increases the Production of Amyloid-β via c-Jun N-Terminal Kinase-Dependent Activation of γ-Secretase
    Cha‐Gyun Jung, Kyung‐Ok Uhm, Hirofumi Horike, Mi‐Jeong Kim, Sachiyo Misumi, Akimasa Ishida, Yoshitomo Ueda, Eun‐Kyoung Choi, Yong‐Sun Kim, Makoto Michikawa et al. · 2014 · Journal of Alzheimer s Disease
  82. Quantitative Proteomics Reveals That ADAM15 Can Have Proteolytic-Independent Functions in the Steady State
    Chun‐Yao Yang, Simone Bonelli, Matteo Calligaris, Anna Paola Carreca, Stephan A. Müller, Stefan F. Lichtenthaler, Linda Troeberg, Simone Dario Scilabra · 2022 · Membranes
  83. HIV-Associated Insults Modulate ADAM10 and Its Regulator Sirtuin1 in an NMDA Receptor-Dependent Manner
    Claudia López Lloreda, Sarah Chowdhury, Shivesh Ghura, Elena Alvarez-Periel, Kelly L. Jordan‐Sciutto · 2022 · Cells
  84. The contribution of N-terminally modified amyloid beta to the etiology of Alzheimer's disease
    Jessica L. Wittnam · 2012
  85. The role of amyloid beta 4-42 in the etiology of Alzheimer's disease
    Yvonne Bouter · 2015
  86. A disintegrin and metalloproteinases (ADAMs) and tumor necrosis factor-alpha-converting enzyme (TACE)
    Doretta Cuffaro, Simone Dario Scilabra, Donatella Pia Spanò, Matteo Calligaris, Elisa Nuti, Armando Rossello · 2023 · Elsevier eBooks
  87. GALM Alleviates Aβ Pathology and Cognitive Deficit Through Increasing ADAM10 Maturation in a Mouse Model of Alzheimer’s Disease
    Na Tian, Junjie Li, Xiuyu Shi, Mingliang Xu, Qian Xiao, Qiuyun Tian, Mulan Chen, Weihong Song, Yehong Du, Zhifang Dong · 2025 · Neuroscience Bulletin
  88. Proteases in the Nervous System
    H. Cynis, S. Lichtenthaler, L. Wagner, H. Demuth · 2013 · Springer eBooks
  89. Soluble Interleukin‐6 Receptor Levels and Risk of Dementia: One More Signpost on a Long Road Ahead
    Madhav Thambisetty, Luigi Ferrucci · 2014 · Journal of the American Geriatrics Society
  90. The Tripeptide RER Mimics Secreted Amyloid Precursor Protein-Alpha in Upregulating LTP
    Jodi A. Morrissey, Erin R. Bigus, Julie Necarsulmer, Vinay Srinivasan, Katie Peppercorn, Daniel J. O’Leary, Bruce G. Mockett, Warren Perry Tate, Stephanie M. Hughes, Karen D. Parfitt et al. · 2019 · Frontiers in Cellular Neuroscience
  91. Contributing Factors of Neurodegeneration in Alzheimer’s Disease
    Breeya A Tailor, Alexander R. Pilozzi, Xudong Huang · 2019 · Codon Publications eBooks
  92. Towards Small Molecules as Therapies for Alzheimer’s Disease and Other Neurodegenerative Disorders
    Omar Aziz, Roland W. Bürli, David F. Fischer, Julie A. Frearson, Michael D. Wall · 2014 · Elsevier eBooks
  93. Key Enzymes and Proteins in Amyloid-Beta Production and Clearance
    C. Santos, I. Cardoso, I. Gonçalves · 2011 · InTech eBooks
  94. The Golgi apparatus in neurorestoration
    Jianyang Liu, Jialin He, Yan Huang, Han Xiao, Zheng Jiang, Zhiping Hu · 2019 · Journal of Neurorestoratology
  95. Targeted Drug Delivery: Amyloid Beta Targeting Drugs, Immunotherapy, Anti-Tau and Aggregation Inhibitor, Microtubule-Stabilizing, and Neuroinflammation Modulation
    Pavan Kumar Chintamaneni, Sai Kiran S. S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Magham Sai Varshini · 2024 · Springer eBooks
  96. The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities
    Renato Brandimarti, Elena Irollo, Olimpia Meucci · 2022 · Molecular Neurobiology
  97. Novel social stimulation ameliorates memory deficit in Alzheimer's disease model through activating α-secretase
    Qiaoyun Ren, Susu Wang, Junru Li, Kun Cao, Mei Zhuang, Miao Wu, Junhua Geng, Zhengping Jia, Wei Xie, An Liu · 2024 · Journal of Neuroscience
  98. β- and γ-secretases as therapeutic targets for Alzheimer's disease
    Gitanjali Swarup, Priti Kanik, Vivek Shekhar, Sharad Kumar Gupta · 2024 · Elsevier eBooks
  99. Yangxue Qingnao Granule in the Treatment of Cerebral Circulation Insufficiency and Cognitive Impairment
    Shengting Li · 2016 · International Journal of Complementary & Alternative Medicine
  100. Interleukin 1 Receptor and Alzheimer’s Disease-Related Neuroinflammation
    Huanhuan Wang, Xizhen Wang · 2017 · InTech eBooks